May 2017
Procore expands activities to penetrate the Canadian Market
Following a pre Investigational Testing Authorization (ITA) meeting with Health Canada, Procore received its first clinical development plan and product designation for RegenoGel as a medical device by the Canadian authorities, with plans towards product registration and commercialization in Canada.